Search results for "Therapeutics"


 
Results 31 - 40 of about 400 for "Therapeutics".
Sort by: Relevance | Newest | Oldest

Hypocoagulopathy

Correct coding and sequencing of codes for patients admitted with hypocoagulopathy can be tricky.
https://acphospitalist.acponline.org/archives/2022/05/18/coding-corner-hypocoagulopathy.htm
18 May 2022

Negative trials of prone positioning, antiplatelet therapy for COVID-19

Telling inpatients to lay on their stomachs did not significantly improve outcomes, one study found, while others offered some mixed results on the effects of aspirin and P2Y12 inhibitors. Additional research showed that a commonly used triage score doesn't work for COVID-19 and that hospitalists' worry about catching the virus impaired their well-being.
https://acphospitalist.acponline.org/archives/2022/03/30/free/negative-trials-of-prone-positioning-antiplatelet-therapy-for-covid-19.htm
30 Mar 2022

Advance care planning assessed, therapeutic heparin debated in recent COVID-19 articles

Along with an analysis of the pre-existing conditions of patients who died of COVID-19 and a point/counterpoint on use of heparin in ward patients, the latest inpatient COVID-19 research included negative trials of losartan and a potential monoclonal antibody.
https://acphospitalist.acponline.org/archives/2022/03/23/free/advance-care-planning-assessed-therapeutic-heparin-debated-in-recent-covid-19-articles.htm
23 Mar 2022

Benefits of dedicated COVID-19 hospitals, ECMO; air sampling after aerosol-generating procedures

A health system reported outcomes at two hospitals created to treat only COVID-19. Another found that 42.9% of COVID-19 patients who got ECMO died, compared to 89.1% when it wasn't available. A sampling study compared viral particles in the air with different procedures.
https://acphospitalist.acponline.org/archives/2022/03/09/free/benefits-of-dedicated-covid-19-hospitals-ECMO-air-sampling-after-aerosol-generating-procedures.htm
9 Mar 2022

Model for COVID-19 triage, updated guidelines for inpatients, negative trial of ivermectin

An electronic health record tool used nine variables to predict which inpatients with COVID-19 would deteriorate. Two societies updated their guidelines on inpatient thromboprophylaxis and remdesivir use. A trial found that ivermectin had no effect on disease progression or mortality.
https://acphospitalist.acponline.org/archives/2022/02/23/free/model-for-covid-19-triage-updated-guidelines-for-inpatients.htm
23 Feb 2022

Microbiome therapeutic reduced risk of recurrent C. difficile infection in phase 3 trial

An industry-funded trial of patients with recurrent Clostridioides difficile infection who received standard-of-care treatment with antibiotics found that those who also received the investigational drug had a 68% lower risk of recurrence than those who received placebo.
https://acphospitalist.acponline.org/archives/2022/01/26/microbiome-therapeutic-reduced-risk-of-recurrent-c-difficile.htm
26 Jan 2022

Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients

An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/free/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022

Novel metric may improve measurement of antibiotic stewardship efforts

Days of antibiotic spectrum coverage may be a more accurate metric than days of therapy for evaluating programs that promote use of narrow-spectrum antibiotic agents, a study found.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/3.htm
22 Dec 2021

Aspirin for COVID-19 inpatients didn't reduce mortality, trial finds

New data from the RECOVERY trial found a slight reduction in clots but an increase in bleeding and no difference in 28-day mortality in patients randomized to daily aspirin during hospitalization compared to those receiving usual care.
https://acphospitalist.acponline.org/weekly/archives/2021/11/24/2.htm
24 Nov 2021

Combating clots in COVID-19

Critical care experts advised on appropriate prophylaxis for ward and ICU patients as part of the CHEST 2021 conference.
https://acphospitalist.acponline.org/archives/2021/11/combating-clots-in-covid-19.htm
15 Nov 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next